We are live on ! Find out more
KAS

Kemnay Advisory Services Portfolio holdings

AUM $865M Turnover 40.99%
1-Year Est. Return 6.6%
This Fund
S&P 500
This Quarter Est. Return
+3.28%
1 Year Est. Return
+6.6%
3 Year Est. Return
+150.85%
5 Year Est. Return
+164.64%
10 Year Est. Return
+663.52%
AUM
$865M
AUM Growth
+$73.8M
Cap. Flow
+$56.3M
Cap. Flow %
6.5%
Top 10 Hldgs %
74.44%
Holding
1,249
New
80
Increased
341
Reduced
389
Closed
432
Avg Time Held
0.7 years
Top 10 Avg Time Held
1.3 years
Top 20 Avg Time Held
3.9 years

Sector Composition

Rank Sector Weight
1 Technology 24.18%
2 Real Estate 23.06%
3 Miscellaneous 17.12%
4 Financials 13.59%
5 Communication Services 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SYY icon
251
Sysco
SYY
$38B
$57.8K 0.01%
742
+136
+22% +$11.2K
2025 Q4
3 quarters
FTNT icon
252
Fortinet
FTNT
$96.6B
$57.7K 0.01%
323
-722
-69% -$117K
2025 Q4
3 quarters
CBOE icon
253
Cboe Global Markets
CBOE
$37.3B
$56.2K 0.01%
204
+118
+137% +$33.4K
2025 Q4
3 quarters
LAUR icon
254
Laureate Education
LAUR
$4.41B
$55.6K 0.01%
1,458
+635
+77% +$23.8K
2025 Q4
3 quarters
PK icon
255
Park Hotels & Resorts
PK
$3.18B
$55.1K 0.01%
3,573
+2,148
+151% +$32.3K
2026 Q2
1 quarter
GRAL icon
256
GRAIL
GRAL
$4.71B
$54.9K 0.01%
392
+39
+11% +$3.09K
2025 Q4
3 quarters
TWST icon
257
Twist Bioscience
TWST
$7.61B
$53.5K 0.01%
277
-272
-50% -$33.6K
2026 Q1
2 quarters
VRTX icon
258
Vertex Pharmaceuticals
VRTX
$132B
$53.3K 0.01%
102
-5
-5% -$2.56K
2025 Q4
3 quarters
CGON icon
259
CG Oncology
CGON
$7.32B
$53K 0.01%
748
+29
+4% +$2.13K
2025 Q4
3 quarters
SYRE icon
260
Spyre Therapeutics
SYRE
$9.27B
$52.6K 0.01%
591
-150
-20% -$14.4K
2026 Q1
2 quarters
TVTX icon
261
Travere Therapeutics
TVTX
$4.64B
$52.6K 0.01%
893
+63
+8% +$3.85K
2026 Q1
2 quarters
NTRA icon
262
Natera
NTRA
$42B
$52.5K 0.01%
127
+68
+115% +$21.4K
2025 Q4
3 quarters
ISRG icon
263
Intuitive Surgical
ISRG
$141B
$52.5K 0.01%
129
-6
-4% -$2.29K
2025 Q4
3 quarters
PGNY icon
264
Progyny
PGNY
$2.61B
$51.8K 0.01%
+2,057
New +$58.2K
2026 Q3
0 quarters
COGT icon
265
Cogent Biosciences
COGT
$4.83B
$51.4K 0.01%
1,605
+118
+8% +$4.36K
2025 Q4
3 quarters
BMY icon
266
Bristol-Myers Squibb
BMY
$119B
$51.3K 0.01%
822
-40
-5% -$2.53K
2025 Q4
3 quarters
PTCT icon
267
PTC Therapeutics
PTCT
$4.87B
$51.2K 0.01%
791
+49
+7% +$3.57K
2025 Q4
3 quarters
IOVA icon
268
Iovance Biotherapeutics
IOVA
$3.38B
$50.7K 0.01%
+3,424
New +$24.5K
2026 Q3
0 quarters
RGTI icon
269
Rigetti Computing
RGTI
$2.76B
$50.1K 0.01%
3,185
+687
+28% +$11.1K
2025 Q4
3 quarters
SRRK icon
270
Scholar Rock
SRRK
$6.15B
$50.1K 0.01%
1,037
+78
+8% +$4.11K
2025 Q4
3 quarters
CRSP icon
271
CRISPR Therapeutics
CRSP
$3.78B
$49.6K 0.01%
897
+54
+6% +$2.91K
2025 Q4
3 quarters
PLD icon
272
Prologis
PLD
$117B
$48.8K 0.01%
376
-1
-0.3% -$140
2025 Q4
3 quarters
RELL icon
273
Richardson Electronics
RELL
$246M
$48.7K 0.01%
+2,746
New +$49.1K
2026 Q3
0 quarters
ENOV icon
274
Enovis
ENOV
$1.51B
$48.6K 0.01%
+2,661
New +$63.3K
2026 Q3
0 quarters
PGR icon
275
Progressive
PGR
$133B
$48.3K 0.01%
233
-8
-3% -$1.73K
2025 Q4
3 quarters

Similar funds

Kemnay Advisory Services's Q3 2026 Portfolio in Review

As of Q3 2026, Kemnay Advisory Services held 1,249 positions worth $865M, up 9.3% from $791M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Kemnay Advisory Services deployed $56.3M of net new capital in Q3 2026, opening 80 new positions and adding to 341 existing holdings. Its largest new stake was Cerebras Systems: 7,197 shares worth $1.28M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 20% a quarter earlier, followed by Real Estate and Miscellaneous.

On the sell side, the largest reduction was Berkshire Hathaway Class B, an estimated $27.9M trimmed.

  • Kemnay Advisory Services's largest Q3 2026 buy was Cerebras Systems: 7,197 shares worth $1.28M.
  • Kemnay Advisory Services added most to iShares MSCI Japan ETF in Q3 2026, an estimated $35.5M increase.
  • Kemnay Advisory Services's biggest Q3 2026 reduction was Berkshire Hathaway Class B, cutting an estimated $27.9M.
  • Kemnay Advisory Services fully exited Figma in Q3 2026, selling an estimated $240K.
  • Kemnay Advisory Services's ten largest holdings make up 74% of its $865M portfolio in Q3 2026.
  • Kemnay Advisory Services opened 80 new positions and closed 432 in Q3 2026.
  • Kemnay Advisory Services's portfolio value rose 9.3% quarter-over-quarter to $865M.

Based on Kemnay Advisory Services's 13F filing for Q3 2026, filed 16 Nov 2026.